<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211338</url>
  </required_header>
  <id_info>
    <org_study_id>HYMC-0061-17</org_study_id>
    <nct_id>NCT03211338</nct_id>
  </id_info>
  <brief_title>Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone</brief_title>
  <official_title>Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the In Vitro and In Vivo effect of progesterone on
      immature myeloid cells (IMC), inflammation characteristics and maturation into dendritic
      cells (DC).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammation characteristic effects of progesterone on preterm and term placentas</measure>
    <time_frame>One year</time_frame>
    <description>Differences observed in cytokine profiles of IMC cells from term and preterm placentas cultured with and without progesterone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maturation effects of progesterone on preterm and term placentas</measure>
    <time_frame>One year</time_frame>
    <description>Differences observed in maturation of IMC cells into DC cells in term and preterm placentas</description>
  </primary_outcome>
  <number_of_arms>12</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Obstetric Labor, Premature</condition>
  <arm_group>
    <arm_group_label>Preterm labor placentas and progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from preterm labor placentas after delivery will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term labor placentas and progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from term labor placentas after delivery will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm labor placentas without progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from preterm labor placentas after delivery will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term labor placentas without progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from term labor placentas after delivery will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term placentas from progesterone treated pregnancies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from term labor placentas from women that were treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm placentas from progesterone treated pregnancies</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from preterm labor placentas from women that were treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term placentas not treated with progesterone in pregnancy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from term placentas from women who were not treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm placentas not treated with progesterone in pregnancy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IMC cells taken from preterm placentas from women who were not treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term postpartum blood samples with progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CD-14+ monocyte cells taken from women delivering at term will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm postpartum blood samples with progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CD-14+ monocyte cells taken from women delivering preterm will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Term postpartum blood samples without progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CD-14+ monocyte cells taken from women delivering at term will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preterm postpartum blood samples without progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CD-14+ monocyte cells taken from women delivering preterm will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Culture with progesterone</intervention_name>
    <description>Progesterone, a steroid hormone will be cultured with placental IMC cells or peripheral blood CD14+ monocyte cells</description>
    <arm_group_label>Preterm labor placentas and progesterone</arm_group_label>
    <arm_group_label>Term labor placentas and progesterone</arm_group_label>
    <arm_group_label>Term postpartum blood samples with progesterone</arm_group_label>
    <arm_group_label>Preterm postpartum blood samples with progesterone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Culture without progesterone</intervention_name>
    <description>Culture of placental IMC cells or peripheral blood CD14+ monocyte cells without progesterone</description>
    <arm_group_label>Preterm labor placentas without progesterone</arm_group_label>
    <arm_group_label>Term labor placentas without progesterone</arm_group_label>
    <arm_group_label>Term postpartum blood samples without progesterone</arm_group_label>
    <arm_group_label>Preterm postpartum blood samples without progesterone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Culture with growth factors</intervention_name>
    <description>Culture of placental IMC cells with growth hormones only and analysis</description>
    <arm_group_label>Term placentas from progesterone treated pregnancies</arm_group_label>
    <arm_group_label>Preterm placentas from progesterone treated pregnancies</arm_group_label>
    <arm_group_label>Term placentas not treated with progesterone in pregnancy</arm_group_label>
    <arm_group_label>Preterm placentas not treated with progesterone in pregnancy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Placentas from term and preterm deliveries

          -  Singleton pregnancy

          -  Consent to participate

        Exclusion Criteria:

          -  Pregnancies with obstetric complications

          -  Multiple gestation

          -  Maternal illness or fetal malformation known pre-delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rinat Gabbay-Benziv, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Suzi Oberman-Farhy, MD</last_name>
    <phone>972-50-7728858</phone>
    <email>suziober@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>H̱adera</city>
        <zip>38100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2017</study_first_submitted>
  <study_first_submitted_qc>July 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Obstetric Labor, Premature</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

